News

In a pivotal randomised controlled trial, the BNT162b2 mRNA vaccine (tozinameran, Pfizer–BioNTech) showed 95% or greater efficacy against symptomatic and severe COVID-19 disease due to SARS-CoV-2. 1 ...
Ribosomes are tiny molecular machines inside all living cells that build proteins, and ribosome biogenesis is the complex, ...